Cited 0 times in Scipus Cited Count

295 (PB075) - Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma

DC Field Value Language
dc.contributor.authorAhn, HR-
dc.contributor.authorEun, JW-
dc.contributor.authorYoon, JH-
dc.contributor.authorSon, JA-
dc.contributor.authorWeon, JH-
dc.contributor.authorBaek, GO-
dc.contributor.authorYoon, MG-
dc.contributor.authorHan, JE-
dc.contributor.authorKwon, M-
dc.contributor.authorKim, SS-
dc.contributor.authorCheong, JY-
dc.contributor.authorCho, HJ-
dc.date.accessioned2023-04-20T04:36:05Z-
dc.date.available2023-04-20T04:36:05Z-
dc.date.issued2022-
dc.identifier.issn0959-8049-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/25256-
dc.language.isoen-
dc.title295 (PB075) - Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma-
dc.typeArticle-
dc.contributor.affiliatedAuthorEun, JW-
dc.contributor.affiliatedAuthorHan, JE-
dc.contributor.affiliatedAuthorKim, SS-
dc.contributor.affiliatedAuthorCheong, JY-
dc.contributor.affiliatedAuthorCho, HJ-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/S0959-8049(22)01079-6-
dc.citation.titleEuropean journal of cancer (Oxford, England : 1990)-
dc.citation.volume174-
dc.citation.numberS1-
dc.citation.date2022-
dc.citation.startPageS105-
dc.citation.endPageS105-
dc.identifier.bibliographicCitationEuropean journal of cancer (Oxford, England : 1990), 174(S1). : S105-S105, 2022-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1879-0852-
dc.relation.journalidJ009598049-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse